
Weill Cornell Medicine has struck a voluntary compliance deal with federal prosecutors that shuts down a yearslong criminal probe and locks the institution into sweeping reforms, including a $30 million pledge to create an Institute for Safe Patient Care and Patient Empowerment. The agreement follows revelations that a former Weill Cornell urologist sexually abused patients over an extended period, targeting vulnerable people who came in for help. Under the deal, the medical school will keep in place new chaperone rules, internal reviews and monitoring that are meant to stop anything like this from happening again.
What the agreement requires
According to the U.S. Attorney's Office for the Southern District of New York, Weill Cornell must commit $30 million and other support to establish the Institute for Safe Patient Care and Patient Empowerment, put a formal chaperone policy in place with routine compliance oversight, run three separate internal reviews of its sexual misconduct prevention programs, and certify its compliance every six months. The U.S. Attorney's Office on X also publicly announced the deal.
Prosecutors' message
"Today's landmark agreement with WCM is a direct reflection of our Office's pledge to prioritize combating sexual abuse," Criminal Division Chief Amanda Houle said in the U.S. Attorney's Office statement. The same statement notes that the deal connects criminal accountability for the individual perpetrator with institutional obligations to strengthen controls, monitor compliance and ensure prompt reporting of misconduct. Prosecutors credited the FBI and NYPD for their investigative work and said the agreement resolves a yearslong probe into failures that allowed patient abuse to continue.
How the abuse unfolded
As reported by the AP, the deal follows the 2024 conviction and life sentence of former urologist Darius Paduch, whom prosecutors said sexually abused patients from roughly 2009 to 2019, including boys as young as 13. Prosecutors said multiple complaints about Paduch were routed to untrained or inexperienced investigators and were not properly escalated by department leaders, which let the abuse continue across institutions. According to the AP, Weill Cornell has already paid or agreed to pay more than $1 billion in civil claims tied to the scandal.
Legal implications
Title III of the Americans with Disabilities Act bars places of public accommodation from discriminating on the basis of disability, and that protection can reach health care settings when patients' medical conditions qualify as disabilities. Background on Title III is available at ADA.gov. Prosecutors have said that certain victims' conditions, including specific genetic disorders and sexual function impairments identified in the investigation, brought this case within the ADA enforcement toolkit, which let them seek remedial obligations that go beyond private civil settlements.
What patients can expect
Weill Cornell has pitched the planned institute as "the first-of-its-kind" for early identification and prevention of sexual misconduct and said the measures adopted under new leadership are intended to make the organization safer, according to the AP. Under the agreement, Weill Cornell must also self-report any future federal crimes involving sexual misconduct to prosecutors and keep the enhanced controls in place for the full term of the compliance plan.
Next steps
In the coming months Weill Cornell is expected to launch the three internal reviews and stand up the Institute for Safe Patient Care and Patient Empowerment, while federal prosecutors keep tabs on the school's semiannual compliance certifications. For victims and advocates, the agreement is both a hefty financial commitment and a real-time policy experiment in whether institutional reforms and outside monitoring can prevent future abuse and rebuild trust in medical settings.









